BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 18360701)

  • 1. The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: assessment of receptor contribution.
    Rouleau C; Menon K; Boutin P; Guyre C; Yoshida H; Kataoka S; Perricone M; Shankara S; Frankel AE; Duesbery NS; Vande Woude G; Biemann HP; Teicher BA
    Int J Oncol; 2008 Apr; 32(4):739-48. PubMed ID: 18360701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic anthrax lethal toxin therapy produces regressions of subcutaneous human melanoma tumors in athymic nude mice.
    Abi-Habib RJ; Singh R; Leppla SH; Greene JJ; Ding Y; Berghuis B; Duesbery NS; Frankel AE
    Clin Cancer Res; 2006 Dec; 12(24):7437-43. PubMed ID: 17189417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthrax lethal toxin inhibits growth of and vascular endothelial growth factor release from endothelial cells expressing the human herpes virus 8 viral G protein coupled receptor.
    Depeille P; Young JJ; Boguslawski EA; Berghuis BD; Kort EJ; Resau JH; Frankel AE; Duesbery NS
    Clin Cancer Res; 2007 Oct; 13(19):5926-34. PubMed ID: 17908989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo.
    Huang D; Ding Y; Luo WM; Bender S; Qian CN; Kort E; Zhang ZF; VandenBeldt K; Duesbery NS; Resau JH; Teh BT
    Cancer Res; 2008 Jan; 68(1):81-8. PubMed ID: 18172299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth-promoting effect of bisphenol A on neuroblastoma in vitro and in vivo.
    Zhu H; Xiao X; Zheng J; Zheng S; Dong K; Yu Y
    J Pediatr Surg; 2009 Apr; 44(4):672-80. PubMed ID: 19361625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and in vitro and in vivo anti-tumor response of an interleukin-2-human serum albumin fusion protein in mice.
    Melder RJ; Osborn BL; Riccobene T; Kanakaraj P; Wei P; Chen G; Stolow D; Halpern WG; Migone TS; Wang Q; Grzegorzewski KJ; Gallant G
    Cancer Immunol Immunother; 2005 Jun; 54(6):535-47. PubMed ID: 15592670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the antitumor activity of recombinant human gamma-interferon employing human melanoma xenografts in athymic nude mice.
    Trotta PP; Harrison SD
    Cancer Res; 1987 Oct; 47(20):5347-53. PubMed ID: 3115565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lupeol inhibits growth of highly aggressive human metastatic melanoma cells in vitro and in vivo by inducing apoptosis.
    Saleem M; Maddodi N; Abu Zaid M; Khan N; bin Hafeez B; Asim M; Suh Y; Yun JM; Setaluri V; Mukhtar H
    Clin Cancer Res; 2008 Apr; 14(7):2119-27. PubMed ID: 18381953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential susceptibility of macrophage cell lines to Bacillus anthracis-Vollum 1B.
    Gutting BW; Gaske KS; Schilling AS; Slaterbeck AF; Sobota L; Mackie RS; Buhr TL
    Toxicol In Vitro; 2005 Mar; 19(2):221-9. PubMed ID: 15649636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.
    Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A
    Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiproliferative effect in vitro and antitumor activity in vivo of brefeldin A.
    Sausville EA; Duncan KL; Senderowicz A; Plowman J; Randazzo PA; Kahn R; Malspeis L; Grever MR
    Cancer J Sci Am; 1996; 2(1):52-8. PubMed ID: 9166499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment parameters modulating regression of human melanoma xenografts by an antibody-drug conjugate (CR011-vcMMAE) targeting GPNMB.
    Pollack VA; Alvarez E; Tse KF; Torgov MY; Xie S; Shenoy SG; MacDougall JR; Arrol S; Zhong H; Gerwien RW; Hahne WF; Senter PD; Jeffers ME; Lichenstein HS; LaRochelle WJ
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):423-35. PubMed ID: 17541593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic activity of Bacillus anthracis protective antigen observed in a macrophage cell line overexpressing ANTXR1.
    Salles II; Voth DE; Ward SC; Averette KM; Tweten RK; Bradley KA; Ballard JD
    Cell Microbiol; 2006 Aug; 8(8):1272-81. PubMed ID: 16882031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 18 kDa isoform of basic fibroblast growth factor is sufficient to stimulate human melanoma growth and angiogenesis.
    Fontijn D; Duyndam MC; Beliƫn JA; Gallegoz Ruiz MI; Pinedo HM; Boven E
    Melanoma Res; 2007 Jun; 17(3):155-68. PubMed ID: 17505261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.
    Zhang Y; Ma Y; Lu HP; Gao JH; Liang CS; Liu CZ; Zou JT; Wang HQ
    Chin Med J (Engl); 2008 Nov; 121(22):2284-9. PubMed ID: 19080333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhein lysinate suppresses the growth of breast cancer cells and potentiates the inhibitory effect of Taxol in athymic mice.
    Lin YJ; Zhen YS
    Anticancer Drugs; 2009 Jan; 20(1):65-72. PubMed ID: 19343002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing monoclonal antibody against anthrax lethal factor inhibits intoxication in a mouse model.
    Zhao P; Liang X; Kalbfleisch J; Koo HM; Cao B
    Hum Antibodies; 2003; 12(4):129-35. PubMed ID: 15156101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of combination therapy using adeno-associated virus--interferon beta and trichostatin A in vitro and in a murine model of neuroblastoma.
    Hamner JB; Sims TL; Cutshaw A; Dickson PV; Rosati S; McGee M; Ng CY; Davidoff AM
    J Pediatr Surg; 2008 Jan; 43(1):177-82; discussion 182-3. PubMed ID: 18206478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.